ClinConnect ClinConnect Logo
Search / Trial NCT04478409

Characterization of a Functional Test for Mediterranean Family Fever Screening - 2

Launched by HOSPICES CIVILS DE LYON · Jul 16, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Familial Mediterranean Fever Interleukin 1β Mefv Gene Mutation Innate Immunity

ClinConnect Summary

This clinical trial is looking at a new, quick test that could help diagnose Familial Mediterranean Fever (FMF), a condition caused by changes in a specific gene called MEFV. FMF is an auto-inflammatory disease that leads to episodes of fever and pain, and understanding whether a patient has the condition can be complicated. The researchers believe that this simple test will be able to tell the difference between patients with FMF and those who do not have it by measuring certain markers in their blood.

To participate in the trial, individuals must be at least 4 years old and have been diagnosed with FMF, confirmed by a genetic test showing at least one mutation in the MEFV gene. Participants can be newly diagnosed or already undergoing treatment. They will need to have a blood test as part of their usual care. It’s important to know that some people, such as those unable to give consent or those with certain infections, cannot participate. If you join the study, you'll help researchers learn more about how to identify and manage this condition better.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Children 4 years of age or older or adults
  • Having a clinical picture compatible with an FMF and a previous genetic analysis finding at least one mutation of the MEFV gene pathogenic or possibly pathogenic for the FMF group;
  • Newly diagnosed or in the process of follow-up (with no time limit or evolutionary criteria);
  • During specific or non-specific treatment of the disease or without treatment;
  • For whom a blood test is planned as part of routine care;
  • Whose informed non-opposition has been collected (or parental non-opposition in the case of a minor patient);
  • Exclusion Criteria:
  • Person under legal protection or under the protection of justice or any other protective measures;
  • Person out of state to express their consent;
  • Person in emergency situation, vital or not;
  • Known infections with HIV and / or HBV and / or HCV;

About Hospices Civils De Lyon

Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.

Locations

Paris, , France

Lyon, , France

Montpellier, , France

Pierre Bénite, , France

Bron, , France

Lyon, , France

Le Chesnay, , France

Nîmes, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials